C
Curiosis
Automated lab solutions for cell analysis and diagnostics
About Curiosis
Curiosis Inc. is a South Korean company founded in 2015 that develops, produces, and supplies laboratory equipment for the life sciences field. The company, led by founder and CEO Hoyoung Yun, focuses on creating solutions to improve the efficiency of cell-based research and diagnostics. Its core technologies are in mechanical engineering, biophysics, and electrical engineering.
The company's product portfolio includes the Celloger® series for live-cell imaging, the FACSCOPE® B automatic cell counter, and the Cellpuri® cell isolation chip. The Celloger® products, such as the Mini, Mini Plus, Nano, Pro, and Stack, provide automated live-cell imaging and monitoring directly inside a CO2 incubator, which helps maintain optimal cell growth conditions and prevents contamination. FACSCOPE® B automates the cell counting process, while Cellpuri® offers a method for cell enrichment without the need for a centrifuge. In 2023, Curiosis also launched the MSP™ 320, a fully automated digital slide scanner for digital pathology applications.
Curiosis serves research institutes, universities, and medical professionals, aiming to enhance the precision and scalability of cell-based studies. The company has expanded its market presence to North America, Europe, China, Japan, and Southeast Asia. Curiosis has received numerous awards and certifications, including two CES Innovation Awards in 2025 for its MSP™-320 & Cellpuri® products, ISO 13485 and ISO 9001 certifications, and was recognized as a "World Class Product of Korea" by KOTRA in 2023.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPO✓Exit | Nov 2025 | $0 | — | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Oct 2024 | $11M | $44M | Timefolio Capital · Kiwoom Investment · Shinhan Capital · STIC Ventures | ↗ |
Growth signals
Latest recorded traffic for Curiosis is 31K monthly website visits, up 181.8% over the last three months. Curiosis's team grew 6.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Curiosis in the Seoul ecosystem
The Curiosis office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later5 investors entered at this stage
SJ Investment Partners- TCTimefolio Capital
- KIKiwoom Investment
- SCShinhan Capital
STIC Ventures
Other known investors1 additional known investor
- AMAlpenroute Asset Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Curiosis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Curiosis’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






